1219
福壽
-0.05 (-0.45%)11.15153成交張數–本益比0.96股價淨值比4.46%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率
營業收入202514,382年增 +0.4%
毛利率20258.5%最新一期
營業利益率20250.0%最新一期
每股盈餘20250.45年增 -15.1%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | – | -1.3% | +8.2% | +4.7% | +0.5% | +19.9% | +15.0% | -4.0% | -12.2% | +0.4% | |
| 營業成本合計 | – | -0.6% | +9.8% | +3.3% | -2.6% | +22.2% | +15.9% | -4.6% | -12.3% | +1.1% | |
| 生物資產當期公允價值減出售成本之變動利益(損失) | – | – | – | – | – | -152.4% | – | – | +305.1% | -170.4% | |
| 營業毛利（毛損） | – | -8.6% | -11.9% | +26.1% | +36.4% | +0.2% | +6.9% | +2.6% | -9.6% | -9.1% | |
| 未實現銷貨（損）益 | – | – | – | – | – | – | – | +57.1% | -64.0% | -8.8% | |
| 已實現銷貨（損）益 | – | – | – | – | – | – | – | – | -8.3% | -64.0% | |
| 營業毛利（毛損）淨額 | – | -8.6% | -11.9% | +26.1% | +36.4% | +0.2% | +6.9% | +2.7% | -9.6% | -9.1% | |
| 營業費用合計 | – | -2.2% | -1.4% | +10.3% | +6.7% | +3.1% | +8.1% | -0.7% | +8.9% | -1.2% | |
| 營業利益（損失） | – | -85.5% | -854.1% | – | +891.3% | -8.7% | +2.4% | +15.2% | -68.6% | -97.1% | |
| 稅前淨利（淨損） | – | -39.5% | -247.9% | – | +285.7% | -47.7% | +6.3% | +3.7% | -64.4% | -82.5% | |
| 所得稅費用（利益）合計 | – | -94.9% | +520.7% | +192.7% | +226.6% | -34.5% | -2.5% | -15.9% | -46.9% | -21.3% | |
| 繼續營業單位本期淨利（淨損） | – | -4.6% | -273.9% | – | +299.8% | -50.2% | +8.6% | +8.3% | -67.6% | -100.5% | |
| 本期淨利（淨損） | – | -4.6% | -273.9% | – | +299.8% | -50.2% | +8.6% | +8.3% | -67.6% | -100.5% | |
| 本期綜合損益總額 | – | +79.3% | -267.3% | – | +311.6% | -50.8% | +11.1% | +5.8% | -65.5% | -100.5% | |
| 母公司業主（淨利∕損） | – | -9.8% | -108.0% | – | +202.9% | -47.5% | -0.3% | -2.9% | -42.0% | -14.5% | |
| 基本每股盈餘 | – | -10.2% | -106.8% | – | +203.2% | -47.6% | 0.0% | -6.0% | -43.6% | -15.1% |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。